|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1989-12-26
|
|
pubmed:abstractText |
Outcome at 6 weeks versus outcome at 9 weeks was compared in 23 patients with syndromally defined episodes of postpsychotic depression who underwent a trial of adjunctive imipramine added to their continuing treatment with fluphenazine decanoate and benztropine. The global outcome after 9 weeks was found to be superior. The implications of this finding for the treatment of secondary depressions in patients with schizophrenia and schizoaffective disorder is discussed.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0010-440X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
483-8
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:2582754-Adult,
pubmed-meshheading:2582754-Affective Disorders, Psychotic,
pubmed-meshheading:2582754-Benztropine,
pubmed-meshheading:2582754-Drug Administration Schedule,
pubmed-meshheading:2582754-Drug Therapy, Combination,
pubmed-meshheading:2582754-Female,
pubmed-meshheading:2582754-Fluphenazine,
pubmed-meshheading:2582754-Follow-Up Studies,
pubmed-meshheading:2582754-Humans,
pubmed-meshheading:2582754-Imipramine,
pubmed-meshheading:2582754-Male,
pubmed-meshheading:2582754-Middle Aged,
pubmed-meshheading:2582754-Psychiatric Status Rating Scales,
pubmed-meshheading:2582754-Psychotic Disorders,
pubmed-meshheading:2582754-Schizophrenia,
pubmed-meshheading:2582754-Schizophrenic Psychology
|
|
pubmed:articleTitle |
Comparison of 6- with 9-week trials of adjunctive imipramine in postpsychotic depression.
|
|
pubmed:affiliation |
Hillside Hospital Division, Long Island Jewish Medical Center, NY.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
